lobbying_activities: 1961636

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1961636	c4a82f3c-14a1-4c57-a49a-4d1920231597	Q1	DAVIS & HARMAN LLP	11674	EMERGENT BIOSOLUTIONS, INC.	2017	first_quarter	DIS	FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures. Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.	HOUSE OF REPRESENTATIVES	20000		0	0	2017-04-19T15:18:46.163000-04:00